Çayan ÇAKIR, Yemlihan CEYLAN, Aykun HAKGOR

Reproducibility of Tilt-table Test with Different Dosages of Sublingual Nitroglycerin

Reproducibility of tilt-table test potentiated with sublingual nitrate is significant since it is directly related to diagnostic accuracy of the test. Nitrates shorten the test time and increase the sensitivity of the test. However the effects of different nitrate dosages on reproducibility have not been reported. Therefore we aimed to investigate the effects of 400 mcg, 800 mcg, and 1200 mcg sublingual nitroglycerin on reproducibility of tilt-table test. All patients undergoing tilt-table test at our hospital due to suspected syncope evaluated and patients giving consent included. First group received 400 mcg, second group received 800 mcg, and third gr oup received 1200 mcg sublingual spray nitroglycerin. Patients underwent a second test with a same protocol within 1 -7 days following the initial test. Overall 189 patients included in this study. All of the patients in the first (n=62) and the second group (n=66) completed the initial test whereas 2 patients in the third group (n=65) terminated the initial test due to severe headache related to nitroglycerin. Five patients in the third group gave exaggerated response. The overall reproducibility of tilt-table test was 81.9%, 88.9%, 82.1%, in the first, second, and third group, respectively. There was no statistically significant reproducibility difference between groups. The reproducibility of tilt-table test is similar with different dosages of sublingual nitroglycerin; however 1200 mcg nitroglycerin has more frequent side effects and exaggerated response.

PDF

___

1- Raviele A, Gasparini G, Di Pede F, et al. Nitroglycerin infusion during upright tilt: A new test for the diagnosis of vasovagal syncope. Am Heart J 1994; 127: 103-111.

2- Aerts A, Dendale P, Strobel G, et al. Sublingual nitrates during head-up tilt testing for the diagnosis of vasovagal syncope. Am Heart J 1997; 133: 504-507.

3- Raviele A, Menozzi C, BrignoleM, et al. Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope. Am J Cardiol 1995; 76: 267-272.

4- Raviele A, Giada F, Brignole M, et al. Comparison of diagnostic accuracy of sublingual nitroglycerin test and low-dose isoproterenol test in patients with unexplained syncope. Am J Cardiol 2000; 85: 1194-1198.

5- Leman RB, Clarke E, Gillette P. Significant complications can occur with ischemic heart disease and tilt table testing. PACE 1999; 22: 675- 677.

6- Pimlott SJ, Addy M. A study into the mucosal absorption of isosorbide dinitrate at different intraoral sites. Oral Med 1985; 59: 145-148.

7- Grubb BP, Wolfe D, Temesey-Armos P, Hahn H, Elliot P. Reproducibility of head-upright tilt table test results in patients with syncope. PACE 1992; 15: 1477-81.

8- Sheldon RS, Splawinski J, Killam SB. Reproducibility of tilt table test in patients with syncope. Am J Cardiol 1992; 69: 1300-1305.

9- Brooks R, Ruskin JN, Powell AC, Newell J, Garan H, McGovern BA. Prospective evaluation of dayto-day reproducibility of upright tilt-table testing in unexplained syncope. Am J Cardiol 1993; 71: 1289-1292.

10- Ruiz GA, Scaglione J, Gonza´lez-Zuelgaray J. Reproducibility of head-up tilt testing in patients with syncope. Clin Cardiol 1996; 19: 215-220.

11- Kou WH, Randall DK, Dorset DN, Koch KS. Immediate reproducibility of tilt-table test results in elderly patients referred for evaluation of syncope or presyncope. Am J Cardiol 1997; 80: 1442-1444.

12- Barón-Esquivias G, Martínez-Rubio A. Tilt table test: state of the art. Indian Pacing Electrophysiol J. 2003; 3: 239-252.

13- Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope.Eur Heart J 2018; 39: 1883-1948.

14- Forleo C, Guida P, Iacoviello M, et al. Head-up tilt testing for diagnosing vasovagal syncope: a meta-analysis. Int J Cardiol 2013; 168: 27-35.

15- Low PA, Sandroni P, Joyner M, Shen WK. Postural tachycardia syndrome (POTS). J Cardiovasc Electrophysiol 2009; 20: 352-358.

16- Timoteo AT, Oliveira MM, Feliciano J, et al. Head-up tilt testing with different nitroglycerin dosages: experience in elderly patients with unexplained syncope. Europace. 2008; 10: 1091- 1094.

17- Koole MAC, Aerts A, Praet J, et al. Venous pooling during nitrate stimulated tilt testing in patients with vasovagal syncope. Europace 2000; 2: 343-345.

18- Jardine DL, Melton IC, Crozier, et al. Neurohormonal response to head-up tilt and its role in vasovagal syncope. Am J Cardiol 1997; 97: 1302-1306.

19- Parker JO, Parker JD. Neurohormonal activation during nitrate therapy: A possible mechanism for tolerance. Am J Cardiol 1992; 70: 93B-7B.

20- Ma A, Long JP. Central noradrenergic activity is responsible for nitroglycerin-induced cardiovascular effects in the nucleus tractus solitarii. Brain Res 1991; 559: 297-303.